Alzheimer’s Disease Protection by Reduced Adenylyl Cyclase Type 5
通过减少 5 型腺苷酸环化酶来预防阿尔茨海默病
基本信息
- 批准号:10526756
- 负责人:
- 金额:$ 43.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-15 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdenylate CyclaseAgeAge-MonthsAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAmyloidAmyloid beta-ProteinApoptosisApplications GrantsBehavioralBiochemicalBrainCell SurvivalCerebrovascular CirculationCyclic AMPDataDementiaDepositionDevelopmentDiabetes MellitusDiseaseExerciseExhibitsFutureGlucoseHealthHeart failureHuman Amyloid Precursor ProteinImpaired cognitionInsulin ResistanceJ20 mouseKnock-outKnockout MiceLaboratoriesLeadLongevityMammalsMemoryMemory LossMetabolicMetabolic dysfunctionMetabolismMitochondriaModelingMolecularMotorMusObesityOrganOrganismOxidative StressPathogenesisPathologyPatientsPerformancePhenotypePlayPopulationPositioning AttributePrevalenceProtein IsoformsReceptor SignalingResearchRoleSenile PlaquesSignal TransductionSynapsesTestingTransgenic AnimalsWild Type MouseYeastsadenylyl cyclase type Vaging brainaging populationbeta-adrenergic receptorbiological adaptation to stressexercise capacityglucose toleranceimprovedindexinginhibitorinsulin tolerancemitochondrial dysfunctionmutantneurofilamentneuroinflammationnew therapeutic targetnoveloverexpressionprotective effectresponsesmall moleculetherapeutic evaluationtherapeutic targetvirtual
项目摘要
Project Summary:
Alzheimer’s Disease (AD) is associated with metabolic dysfunction, glucose and insulin resistance, oxidative
stress, mitochondrial dysfunction, and reduced exercise capacity. Oxidative stress and mitochondrial dysfunction
correlate with the development of beta-amyloid (Aβ) deposits, one of the hallmarks of AD that begin years before
the onset of memory and cognitive decline. Moreover, patients with AD have a reduced lifespan. Accordingly, it
would be beneficial to examine novel models of healthful longevity with enhanced metabolism, glucose and
insulin tolerance, exercise capacity, and protection against oxidative stress, mitochondrial dysfunction, and
apoptosis. All these features are present in the adenylyl cyclase type 5 (AC5) knock out (KO) mouse, which
exhibits healthful longevity, associated with all major molecular factors that protect against AD. Adenylyl cyclase
(AC) induces cyclic AMP (cAMP) and, therefore, regulates sympathetic control and β-adrenergic receptor (β-
AR) signaling, and is thus a key regulator of health and longevity in organisms ranging from yeast to mammals.
AC5 is one of ten AC isoforms and is expressed in virtually every organ in the body, including the brain. In
support of its role in aging, we have found that disruption of AC5 (AC5 KO) promotes healthful longevity,
enhances exercise performance and protects against diabetes and heart failure, all of which should be helpful
in protecting against AD. Our preliminary data also show that AC5 KO mice perform better on memory and motor
tasks compared to wild-type mice. In contrast, the Alzheimer model J20 mice, a transgenic animal that
overexpresses mutant human amyloid precursor protein (APP), exhibits memory loss as expected. We
hypothesize that the AC5 KO mouse and the brain-specific AC5 KO mice (AC5 BKO) are models for protection
against AD and that J20 mice lacking AC5 will be protected from amyloid Aβ related pathology. The first specific
aim will determine whether AC5 plays a role in AD-related pathology and whether deleting it mitigates the J20
phenotype. And the second specific aim will determine whether the enhanced performance of AC5 KO mice is
due to its systemic actions or whether selective deletion of AC5 in the brain is sufficient to have a beneficial effect
on AD-like phenotype. Importantly, all mouse lines needed to address these questions are available to us for
study.
项目总结:
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
M. Maral Mouradian其他文献
M. Maral Mouradian的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('M. Maral Mouradian', 18)}}的其他基金
PME-1: Pathogenetic Role and Therapeutic Opportunity in Neurodegenerative Mixed Proteinopathies
PME-1:神经退行性混合蛋白病的致病作用和治疗机会
- 批准号:
10595891 - 财政年份:2023
- 资助金额:
$ 43.18万 - 项目类别:
Role of Transglutaminase 2 in Synucleinopathies
转谷氨酰胺酶 2 在突触核蛋白病中的作用
- 批准号:
10285001 - 财政年份:2021
- 资助金额:
$ 43.18万 - 项目类别:
Training in Translating Neuroscience to Therapies
将神经科学转化为治疗的培训
- 批准号:
10442401 - 财政年份:2021
- 资助金额:
$ 43.18万 - 项目类别:
Training in Translating Neuroscience to Therapies
将神经科学转化为治疗的培训
- 批准号:
10204266 - 财政年份:2021
- 资助金额:
$ 43.18万 - 项目类别:
Training in Translating Neuroscience to Therapies
将神经科学转化为治疗的培训
- 批准号:
10621360 - 财政年份:2021
- 资助金额:
$ 43.18万 - 项目类别:
PP2A Dysregulation in the Pathogenesis of alpha-Synucleinopathies
α-突触核蛋白病发病机制中的 PP2A 失调
- 批准号:
9920223 - 财政年份:2017
- 资助金额:
$ 43.18万 - 项目类别:
Manipulating Gene Expression in the Dyskinesias of Parkinson's Disease
操纵帕金森病运动障碍中的基因表达
- 批准号:
9305587 - 财政年份:2016
- 资助金额:
$ 43.18万 - 项目类别:
Synergistic Neuroprotective Mechanisms of Coffee Components in Parkinson's Diseas
咖啡成分对帕金森病的协同神经保护机制
- 批准号:
8700581 - 财政年份:2012
- 资助金额:
$ 43.18万 - 项目类别:
Synergistic Neuroprotective Mechanisms of Coffee Components in Parkinson's Diseas
咖啡成分对帕金森病的协同神经保护机制
- 批准号:
8368832 - 财政年份:2012
- 资助金额:
$ 43.18万 - 项目类别:
Synergistic Neuroprotective Mechanisms of Coffee Components in Parkinson's Diseas
咖啡成分对帕金森病的协同神经保护机制
- 批准号:
8543640 - 财政年份:2012
- 资助金额:
$ 43.18万 - 项目类别:
相似海外基金
Neuroendocrine regulation of energy metabolism: role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the thermoregulatory cascade
能量代谢的神经内分泌调节:垂体腺苷酸环化酶激活多肽(PACAP)在温度调节级联中的作用
- 批准号:
RGPIN-2021-04040 - 财政年份:2022
- 资助金额:
$ 43.18万 - 项目类别:
Discovery Grants Program - Individual
Controlled Release of Pituitary Adenylate Cyclase Activating Polypeptide from a Hydrogel-Nanoparticle Delivery Vehicle for Applications in the Central Nervous System
从水凝胶-纳米粒子递送载体中控制释放垂体腺苷酸环化酶激活多肽,用于中枢神经系统的应用
- 批准号:
547124-2020 - 财政年份:2022
- 资助金额:
$ 43.18万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Controlled Release of Pituitary Adenylate Cyclase Activating Polypeptide from a Hydrogel-Nanoparticle Delivery Vehicle for Applications in the Central Nervous System
从水凝胶-纳米粒子递送载体中控制释放垂体腺苷酸环化酶激活多肽,用于中枢神经系统的应用
- 批准号:
547124-2020 - 财政年份:2021
- 资助金额:
$ 43.18万 - 项目类别:
Postgraduate Scholarships - Doctoral
Neuroendocrine regulation of energy metabolism: role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the thermoregulatory cascade
能量代谢的神经内分泌调节:垂体腺苷酸环化酶激活多肽(PACAP)在温度调节级联中的作用
- 批准号:
RGPIN-2021-04040 - 财政年份:2021
- 资助金额:
$ 43.18万 - 项目类别:
Discovery Grants Program - Individual
The Molecular Mechanism of the Secretion of the Bacterial Toxin Adenylate Cyclase
细菌毒素腺苷酸环化酶分泌的分子机制
- 批准号:
451966 - 财政年份:2021
- 资助金额:
$ 43.18万 - 项目类别:
Operating Grants
The role of prefrontostriatal Pituitary Adenylate Cyclase Activating Polypeptide in excessive and compulsive ethanol drinking
前额纹状体垂体腺苷酸环化酶激活多肽在过量和强迫性乙醇饮酒中的作用
- 批准号:
10261394 - 财政年份:2020
- 资助金额:
$ 43.18万 - 项目类别:
The role of prefrontostriatal Pituitary Adenylate Cyclase Activating Polypeptide in excessive and compulsive ethanol drinking
前额纹状体垂体腺苷酸环化酶激活多肽在过量和强迫性乙醇饮酒中的作用
- 批准号:
10455587 - 财政年份:2020
- 资助金额:
$ 43.18万 - 项目类别:
Diagnosis and therapeutic effect of neurally mediated syncope (NMS) using fluctuation of adenylate cyclase activity
利用腺苷酸环化酶活性波动对神经介导性晕厥(NMS)的诊断和治疗效果
- 批准号:
20K08498 - 财政年份:2020
- 资助金额:
$ 43.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pituitary adenylate cyclase-activating polypeptide 27 in the paraventricular thalamus and its projections: Role in ethanol drinking
室旁丘脑中的垂体腺苷酸环化酶激活多肽 27 及其预测:在乙醇饮用中的作用
- 批准号:
10380126 - 财政年份:2020
- 资助金额:
$ 43.18万 - 项目类别:
The role of prefrontostriatal Pituitary Adenylate Cyclase Activating Polypeptide in excessive and compulsive ethanol drinking
前额纹状体垂体腺苷酸环化酶激活多肽在过量和强迫性乙醇饮酒中的作用
- 批准号:
10662279 - 财政年份:2020
- 资助金额:
$ 43.18万 - 项目类别:














{{item.name}}会员




